Dopamine synthesis and D3 receptor activation in pancreatic β-cells regulates insulin secretion and intracellular [Ca2+] oscillations

Molecular Endocrinology

Volumn 26, Issue 11, 2012, Pages 1928-1940

  Ustione, Alessandro ^a   Piston, David W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; LEVODOPA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; INSULIN RELEASE; MOUSE; NEGATIVE FEEDBACK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CALCIUM SIGNALING; DOPAMINE; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; INTRACELLULAR SPACE; LEVODOPA; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; PROTEIN TRANSPORT; RECEPTORS, DOPAMINE D3; SUBCELLULAR FRACTIONS;

EID: 84868129185     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1226     Document Type: Article

References (69)

1. Leahy JL 2005 Pathogenesis of type 2 diabetes mellitus. Arch Med Res 36:197-209
2. Leahy JL, Hirsch IB, Peterson KA, Schneider D 2010 Targeting β-cell function early in the course of therapy for type 2 diabetes mellitus. J Clin Endocrinol Metab 95:4206-4216
3. Weyer C, Bogardus C, Mott DM, Pratley RE 1999 The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794
4. Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC 2005 Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 53:1087-1097
5. Benninger RK, Zhang M, Head WS, Satin LS, PistonDW 2008 Gap junction coupling and calcium waves in the pancreatic islet. Biophys J 95:5048-5061
6. Hopcroft DW, Mason DR, Scott RS 1985 Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion. Endocrinology 117:2073-2080
7. Kanno T, Gopel SO, Rorsman P, Wakui M 2002 Cellular function in multicellular system for hormone-secretion: electrophysiological aspect of studies on α-, β-and δ-cells of the pancreatic islet. Neurosci Res 42:79-90
8. Ahrén B 2009 Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8:369-385
9. Winzell MS, Ahrén B 2007 G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol Ther 116:437-448
10. Miller RE 1981 Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the Islets of Langerhans. Endocr Rev 2:471-494
11. Beaulieu JM, Gainetdinov RR 2011 The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182-217
12. Wood-Kaczmar A, Gandhi S, Wood NW 2006 Understanding the molecular causes of Parkinson's disease. Trends Mol Med 12:521-528
13. Abi-Dargham A 2004 Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7(Suppl 1):S 1-S 5
14. Grace AA 2010 Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress. Neurotox Res 18:367-376
15. Lodge DJ, Grace AA 2010 Developmental pathology, dopamine, stress and schizophrenia. Int J Dev Neurosci 29:207-213
16. Falck B, Hellman B 1963 Evidence for the presence of biogenic amines in pancreatic islets. Cell Mol Life Sci 19:139-140
17. Pearse AG 1968 Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin. Proc R Soc Lond B Biol Sci 170:71-80
18. 2+ efflux and insulin secretion in isolated rat islets. Pharmacology 30:71-82
19. Ericson LE, Håkanson R, Lundquist I 1977 Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia 13:117-124
20. Lundquist I, Panagiotidis G, Stenstrom̈ A 1991 Effect of L-dopa administration on islet monoamine oxidase activity and glucoseinduced insulin release in the mouse. Pancreas 6:522-527
21. Lundquist I, Ahrén B, Hansson C, Håkanson R 1989 Monoamines in pancreatic islets of guinea pig, hamster, rat, and mouse determined by high performance liquid chromatography. Pancreas 4:662-667
22. Falck B, Hellman B 1964 A fluorescent reaction for monoamines in the insulin producing cells of the guinea-pig. Acta Endocrinol (Copenh) 45:133-138
23. Håkanson R, Lundquist I, Rerup C 1967 On the hyperglycaemic effect of DOPA and dopamine. Eur J Pharmacol 1:114-119
24. Cegrell L 1968 The occurrence of biogenic monoamines in the mammalian endocrine pancreas. Acta Physiol Scand Suppl 314: 1-60
25. Feldman JM, Lebovitz HE 1971 The nature of the interaction of amines with the pancreatic β cells to influence insulin secretion. J Pharmacol Exp Ther 179:56-65
26. Quickel Jr KE, Feldman JM, Lebovitz HE 1971 Inhibition of insulin secretion by serotonin and dopamine: species variation. Endocrinology 89:1295-1302
27. Wilson JP, Downs RW, Feldman JM, Lebovitz HE 1974 β Cell monoamines: further evidence for their role in modulating insulin secretion. Am J Physiol 227:305-312
28. Feldman JM 1979 Species variation in the islets of Langerhans. Diabetologia 16:1-4
29. Lindström P 1986 Aromatic-L-amino-acid decarboxylase activity in mouse pancreatic islets. Biochim Biophys Acta 884:276-281
30. Teitelman G, Joh TH, Reis DJ 1981 Transformation of catecholaminergic precursors into glucagon (A) cells in mouse embryonic pancreas. Proc Natl Acad Sci USA 78:5225-5229
31. Harris PE, Ferrara C, Barba P, Polito T, Freeby M, Maffei A 2008 VMAT 2 gene expression and function as it applies to imaging β-cell mass. J Mol Med 86:5-16
32. Raffo A, Hancock K, Polito T, Xie Y, Andan G, Witkowski P, Hardy M, Barba P, Ferrara C, Maffei A, Freeby M, Goland R, Leibel RL, Sweet IR, Harris PE 2008 Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. J Endocrinol 198:41-49
33. Rubi B, Ljubicic S, Pournourmohammadi S, Carobbio S, Armanet M, Bartley C, Maechler P 2005 Dopamine D 2-like receptors are expressed in pancreatic β cells and mediate inhibition of insulin secretion. J Biol Chem 280:36824-36832
34. Garcia-Tornadú I, Ornstein AM, Chamson-Reig A, Wheeler MB, Hill DJ, Arany E, Rubinstein M, Becu-Villalobos D 2010 Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance. Endocrinology 151:1441-1450
35. WuW, Shang J, Feng Y, Thompson CM, Horwitz S, Thompson JR, MacIntyre ED, Thornberry NA, Chapman K, Zhou YP, Howard AD, Li J 2008 Identification of glucose-dependant insulin secretion targets in pancreatic β cells by combining defined-mechanism compound library screening and siRNA gene silencing. J Biomol Screen 13:128-134
36. Eisenhofer G, Aneman A, Friberg P, Hooper D, Fåndriks L, Lonroth H, Hunyady B, Mezey E 1997 Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82:3864-3871
37. Eisenhofer G, Kopin IJ, Goldstein DS 2004 Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331-349
38. Goldstein DS, Eisenhofer G, Kopin IJ 2003 Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305:800-811
39. Mezey E, Eisenhofer G, Harta G, Hansson S, Gould L, Hunyady B, Hoffman BJ 1996 A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proc Natl Acad Sci USA 93:10377-10382
40. Eldrup E 2004 Significance and origin of DOPA, DOPAC, and dopamine-sulphate in plasma, tissues and cerebrospinal fluid. Dan Med Bull 51:34-62
41. Keller NR, Diedrich A, Appalsamy M, Tuntrakool S, Lonce S, Finney C, Caron MG, Robertson D 2004 Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity. Circulation 110: 1191-1196
42. Girault JA, Greengard P 2004 The neurobiology of dopamine signaling. Arch Neurol 61:641-644
43. Piston DW, Knobel SM 1999 Quantitative imaging of metabolism by two-photon excitation microscopy. Methods Enzymol 307:351-368
44. Eng J, Lynch RM, Balaban RS 1989 Nicotinamide adenine dinucleotide fluorescence spectroscopy and imaging of isolated cardiac myocytes. Biophys J 55:621-630
45. MacDonald PE, Rorsman P 2006 Oscillations, intercellular coupling, and insulin secretion in pancreatic β cells. Plos Biol 4:167-171
46. Rubi{dotless}́ B, Maechler P 2010 Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance. Endocrinology 151:5570-5581
47. Hansen SE, Hedeskov CJ 1977 Simultaneous determination of the content of serotonin, dopamine, noradrenaline and adrenaline in pancreatic islets isolated from fed and starved mice. Acta Endocrinol (Copenh) 86:820-832
48. Tjurmina OA, Armando I, Saavedra JM, Goldstein DS, Murphy DL 2002 Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 143:4520-4526
49. Bergsten P, Moura AS, Atwater I, Levine M 1994 Ascorbic acid and insulin secretion in pancreatic islets. J Biol Chem 269:1041-1045
50. 2+ in rat pancreatic islets. Proc Natl Acad Sci USA 92:10728-10732
51. Sandyk R 1993 The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 69:125-130
52. Sirtori CR, Bolme P, Azarnoff DL 1972 Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism. N Engl J Med 287:729-733
53. Craft S, Watson GS 2004 Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3:169-178
54. Driver JA, Smith A, Buring JE, Gaziano JM, Kurth T, Logroscino G 2008 Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 31:2003-2005
55. 2+ channels is dependent on a shank-binding domain. J Neurosci 25:1050-1062
56. 2+ currents and excitability via a novel PLCβ1-IP 3-calcineurin-signaling cascade. J Neurosci 20:8987-8995
57. Barrett E, Blonde L, Clement S, Davis J, Devlin J, Kone J, Klein S, Torrey W 2004 Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27:596-601
58. Girgis RR, Javitch JA, Lieberman JA 2008 Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway. Mol Psychiatry 13:918-929
59. Melkersson K, Dahl ML 2004 Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Drugs 64:701-723
60. Miller LJ 2009 Management of atypical antipsychotic drug-induced weight gain: focus on metformin. Pharmacotherapy 29:725-735
61. Pramyothin P, Khaodhiar L 2010 Metabolic syndrome with the atypical antipsychotics. Curr Opin Endocrinol Diabetes Obes 17: 460-466
62. Horowitz MP, Greenamyre JT 2010 Gene-environment interactions in Parkinson's disease: the importance of animal modeling. Clin Pharmacol Ther 88:467-474
63. Sanyal J, Chakraborty DP, Sarkar B, Banerjee TK, Mukherjee SC, Ray BC, Rao VR 2010 Environmental and familial risk factors of Parkinsons disease: case-control study. Can J Neurol Sci 37:637-642
64. Vance JM, Ali S, Bradley WG, Singer C, Di Monte DA 2010 Geneenvironment interactions in Parkinson's disease and other forms of parkinsonism. Neurotoxicology 31:598-602
65. Lacy PE, Kostianovsky M 1967 Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35-39
66. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K 1990 Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127: 126-132
67. Easley CJ, Benninger RK, Shaver JH, Steven Head W, Piston DW 2009 Rapid and inexpensive fabrication of polymeric microfluidic devices via toner transfer masking. Lab Chip 9:1119-1127
68. Rasband WS 1997-2009 ImageJ, U S National Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/
69. Uhlén P 2004 Spectral analysis of calcium oscillations. Sci STKE 2004:pl15